| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diaphragm | 35 | 2025 | 98 | 7.220 |
Why?
|
| Muscle Contraction | 24 | 2021 | 154 | 4.100 |
Why?
|
| Respiratory Mechanics | 19 | 2022 | 78 | 3.300 |
Why?
|
| Mechanotransduction, Cellular | 8 | 2025 | 73 | 3.260 |
Why?
|
| Muscle, Skeletal | 19 | 2024 | 1035 | 2.920 |
Why?
|
| Muscle Fibers, Skeletal | 15 | 2021 | 110 | 2.370 |
Why?
|
| Muscle Proteins | 8 | 2024 | 404 | 2.180 |
Why?
|
| Sirtuin 1 | 5 | 2020 | 54 | 2.080 |
Why?
|
| MicroRNAs | 7 | 2025 | 915 | 1.760 |
Why?
|
| NF-kappa B | 7 | 2024 | 454 | 1.680 |
Why?
|
| Stress, Mechanical | 19 | 2020 | 170 | 1.630 |
Why?
|
| Muscular Dystrophies | 4 | 2024 | 54 | 1.310 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 9 | 2018 | 628 | 1.180 |
Why?
|
| Early Growth Response Protein 1 | 4 | 2012 | 38 | 1.150 |
Why?
|
| Desmin | 4 | 2011 | 20 | 1.150 |
Why?
|
| Muscle Development | 2 | 2025 | 73 | 1.120 |
Why?
|
| Dogs | 22 | 2017 | 651 | 1.070 |
Why?
|
| Muscle, Smooth | 5 | 2011 | 131 | 0.990 |
Why?
|
| Models, Biological | 14 | 2017 | 1445 | 0.980 |
Why?
|
| Cytoskeleton | 3 | 2025 | 168 | 0.930 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2025 | 31 | 0.930 |
Why?
|
| Repressor Proteins | 3 | 2024 | 812 | 0.930 |
Why?
|
| Animals | 58 | 2025 | 34842 | 0.930 |
Why?
|
| Dystrophin | 2 | 2021 | 41 | 0.910 |
Why?
|
| Respiratory System | 5 | 2016 | 98 | 0.880 |
Why?
|
| Posture | 4 | 2017 | 144 | 0.880 |
Why?
|
| Up-Regulation | 4 | 2024 | 880 | 0.850 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2021 | 66 | 0.850 |
Why?
|
| Thorax | 4 | 2022 | 73 | 0.840 |
Why?
|
| Muscle Strength | 3 | 2018 | 86 | 0.840 |
Why?
|
| Prostheses and Implants | 1 | 2025 | 153 | 0.840 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2011 | 189 | 0.790 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 2442 | 0.730 |
Why?
|
| Lung | 7 | 2017 | 1556 | 0.720 |
Why?
|
| Respiratory Muscles | 2 | 2011 | 7 | 0.710 |
Why?
|
| Aging | 4 | 2020 | 1251 | 0.690 |
Why?
|
| Tidal Volume | 3 | 2017 | 41 | 0.650 |
Why?
|
| Fibroblasts | 1 | 2024 | 862 | 0.640 |
Why?
|
| Myoblasts | 2 | 2025 | 37 | 0.630 |
Why?
|
| Obesity | 4 | 2020 | 2398 | 0.630 |
Why?
|
| Mice | 26 | 2025 | 18504 | 0.610 |
Why?
|
| Forced Expiratory Volume | 7 | 2017 | 173 | 0.610 |
Why?
|
| Transcription Factor AP-1 | 5 | 2010 | 111 | 0.610 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2010 | 231 | 0.600 |
Why?
|
| Muscular Dystrophy, Animal | 3 | 2024 | 10 | 0.600 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4690 | 0.570 |
Why?
|
| Signal Transduction | 11 | 2025 | 4720 | 0.540 |
Why?
|
| Abdominal Muscles | 3 | 2011 | 28 | 0.510 |
Why?
|
| Tendons | 5 | 2005 | 37 | 0.490 |
Why?
|
| Respiratory Function Tests | 4 | 2006 | 212 | 0.490 |
Why?
|
| Biomechanical Phenomena | 9 | 2011 | 229 | 0.470 |
Why?
|
| Mitochondrial Turnover | 1 | 2014 | 3 | 0.440 |
Why?
|
| Weight-Bearing | 3 | 2004 | 44 | 0.430 |
Why?
|
| Computer Simulation | 5 | 2010 | 700 | 0.430 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 200 | 0.430 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 61 | 0.420 |
Why?
|
| Supine Position | 8 | 2011 | 24 | 0.420 |
Why?
|
| Nuclear Proteins | 3 | 2024 | 1284 | 0.420 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 62 | 0.420 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2013 | 11 | 0.410 |
Why?
|
| Hypertrophy | 2 | 2011 | 101 | 0.410 |
Why?
|
| Cell Differentiation | 3 | 2025 | 1964 | 0.410 |
Why?
|
| Asthma | 3 | 2006 | 773 | 0.400 |
Why?
|
| Elasticity | 7 | 2008 | 78 | 0.400 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 386 | 0.390 |
Why?
|
| Exercise | 4 | 2020 | 860 | 0.380 |
Why?
|
| Promoter Regions, Genetic | 6 | 2013 | 1284 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 502 | 0.360 |
Why?
|
| Myositis | 2 | 2013 | 105 | 0.360 |
Why?
|
| Prone Position | 7 | 2011 | 33 | 0.360 |
Why?
|
| Ribs | 2 | 2010 | 54 | 0.350 |
Why?
|
| Compliance | 3 | 2008 | 18 | 0.340 |
Why?
|
| Gases | 2 | 2000 | 20 | 0.340 |
Why?
|
| Altitude | 2 | 2000 | 23 | 0.340 |
Why?
|
| Cells, Cultured | 7 | 2013 | 3046 | 0.340 |
Why?
|
| MyoD Protein | 2 | 2025 | 24 | 0.340 |
Why?
|
| Cell Nucleus | 1 | 2013 | 592 | 0.340 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2010 | 343 | 0.330 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 47 | 0.330 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 176 | 0.320 |
Why?
|
| rho-Associated Kinases | 1 | 2010 | 51 | 0.320 |
Why?
|
| Trachea | 1 | 2011 | 210 | 0.320 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 133 | 0.310 |
Why?
|
| Oxidative Stress | 4 | 2020 | 801 | 0.300 |
Why?
|
| Pulmonary Ventilation | 1 | 2008 | 29 | 0.280 |
Why?
|
| Antioxidants | 1 | 2010 | 333 | 0.280 |
Why?
|
| Homeostasis | 1 | 2012 | 722 | 0.280 |
Why?
|
| Total Lung Capacity | 4 | 2017 | 13 | 0.280 |
Why?
|
| Blotting, Western | 4 | 2011 | 1080 | 0.280 |
Why?
|
| Anisotropy | 3 | 2022 | 122 | 0.280 |
Why?
|
| Airway Resistance | 2 | 2011 | 32 | 0.270 |
Why?
|
| Genomics | 1 | 2015 | 1652 | 0.260 |
Why?
|
| Protein Kinases | 1 | 2008 | 331 | 0.260 |
Why?
|
| Cytoskeletal Proteins | 2 | 2010 | 282 | 0.260 |
Why?
|
| Albuterol | 1 | 2006 | 49 | 0.250 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 1285 | 0.250 |
Why?
|
| Interleukin-1 | 2 | 2003 | 135 | 0.240 |
Why?
|
| Transcription Factors | 2 | 2014 | 2490 | 0.240 |
Why?
|
| RNA-Binding Proteins | 2 | 2022 | 607 | 0.230 |
Why?
|
| Forkhead Transcription Factors | 1 | 2008 | 387 | 0.230 |
Why?
|
| Humans | 30 | 2025 | 132199 | 0.230 |
Why?
|
| Bronchodilator Agents | 1 | 2006 | 150 | 0.230 |
Why?
|
| Isometric Contraction | 2 | 2021 | 24 | 0.230 |
Why?
|
| Pressure | 3 | 2022 | 131 | 0.230 |
Why?
|
| Biocompatible Materials | 1 | 2025 | 125 | 0.220 |
Why?
|
| Integrins | 1 | 2005 | 94 | 0.220 |
Why?
|
| In Vitro Techniques | 5 | 2010 | 862 | 0.220 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 68 | 0.220 |
Why?
|
| Surface Properties | 1 | 2024 | 93 | 0.210 |
Why?
|
| Pulmonary Emphysema | 1 | 2005 | 94 | 0.210 |
Why?
|
| Pneumonectomy | 1 | 2005 | 148 | 0.210 |
Why?
|
| CCAAT-Binding Factor | 1 | 2003 | 6 | 0.200 |
Why?
|
| Functional Residual Capacity | 4 | 2017 | 15 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 2449 | 0.200 |
Why?
|
| Laminin | 1 | 2003 | 72 | 0.200 |
Why?
|
| NF-KappaB Inhibitor alpha | 3 | 2011 | 33 | 0.190 |
Why?
|
| I-kappa B Proteins | 3 | 2011 | 39 | 0.190 |
Why?
|
| I-kappa B Kinase | 3 | 2011 | 58 | 0.190 |
Why?
|
| Vital Capacity | 2 | 2017 | 86 | 0.190 |
Why?
|
| Quality of Life | 3 | 2017 | 2161 | 0.190 |
Why?
|
| Decompression Sickness | 2 | 2003 | 4 | 0.190 |
Why?
|
| Enzyme Activation | 4 | 2004 | 617 | 0.190 |
Why?
|
| Smoking | 2 | 2018 | 940 | 0.180 |
Why?
|
| Cell Line | 4 | 2012 | 2724 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 2165 | 0.170 |
Why?
|
| Decompression | 1 | 2000 | 4 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 309 | 0.170 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 420 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 6 | 2011 | 4758 | 0.170 |
Why?
|
| Muscle Cells | 3 | 2022 | 27 | 0.170 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 157 | 0.170 |
Why?
|
| Mutation | 3 | 2010 | 6243 | 0.160 |
Why?
|
| NAD | 1 | 2020 | 52 | 0.160 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2010 | 236 | 0.160 |
Why?
|
| Culture Techniques | 3 | 2004 | 75 | 0.160 |
Why?
|
| Protein Domains | 1 | 2020 | 260 | 0.150 |
Why?
|
| Respiration | 1 | 1999 | 123 | 0.150 |
Why?
|
| Inflammation | 2 | 2020 | 1520 | 0.150 |
Why?
|
| Models, Anatomic | 3 | 2006 | 104 | 0.150 |
Why?
|
| Pectoralis Muscles | 1 | 2018 | 8 | 0.140 |
Why?
|
| Hypoxia | 1 | 2020 | 259 | 0.140 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2010 | 215 | 0.140 |
Why?
|
| Smokers | 1 | 2018 | 44 | 0.140 |
Why?
|
| Risk | 1 | 2020 | 761 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 361 | 0.140 |
Why?
|
| Iowa | 1 | 2017 | 13 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 1045 | 0.140 |
Why?
|
| Peptide Initiation Factors | 1 | 2017 | 28 | 0.130 |
Why?
|
| RNA, Messenger | 4 | 2011 | 2679 | 0.130 |
Why?
|
| DNA Damage | 1 | 2020 | 511 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2010 | 93 | 0.130 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 3091 | 0.130 |
Why?
|
| DNA Primers | 2 | 2011 | 636 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 365 | 0.130 |
Why?
|
| Bronchitis, Chronic | 1 | 2016 | 19 | 0.120 |
Why?
|
| Apoptosis | 2 | 2017 | 1901 | 0.120 |
Why?
|
| Enzyme Inhibitors | 3 | 2004 | 589 | 0.120 |
Why?
|
| Middle Aged | 10 | 2018 | 29007 | 0.120 |
Why?
|
| Organ Size | 1 | 2017 | 446 | 0.120 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 377 | 0.120 |
Why?
|
| Disease Progression | 3 | 2017 | 2230 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2020 | 698 | 0.110 |
Why?
|
| Mice, Knockout | 5 | 2011 | 3868 | 0.110 |
Why?
|
| Mice, Obese | 1 | 2014 | 76 | 0.110 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 44 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2017 | 1699 | 0.110 |
Why?
|
| Physical Stimulation | 2 | 2005 | 38 | 0.110 |
Why?
|
| Mitochondria, Muscle | 1 | 2014 | 38 | 0.110 |
Why?
|
| Radiography | 3 | 2006 | 819 | 0.100 |
Why?
|
| Mice, Inbred mdx | 2 | 2004 | 44 | 0.100 |
Why?
|
| Base Sequence | 2 | 2011 | 2900 | 0.100 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 31 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2010 | 1611 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2003 | 125 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2013 | 120 | 0.100 |
Why?
|
| Flavonoids | 2 | 2004 | 86 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 255 | 0.090 |
Why?
|
| Aged | 7 | 2018 | 21456 | 0.090 |
Why?
|
| Hindlimb | 2 | 2003 | 76 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 689 | 0.090 |
Why?
|
| Ion Channels | 2 | 2004 | 206 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 3760 | 0.090 |
Why?
|
| DNA | 2 | 2010 | 1479 | 0.090 |
Why?
|
| Male | 11 | 2018 | 64979 | 0.090 |
Why?
|
| Female | 10 | 2018 | 70754 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 310 | 0.090 |
Why?
|
| Muscle Stretching Exercises | 1 | 2010 | 1 | 0.090 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2010 | 11 | 0.090 |
Why?
|
| Poisson Distribution | 2 | 2000 | 51 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 398 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 3356 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2010 | 38 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 60 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3414 | 0.080 |
Why?
|
| Histocytochemistry | 2 | 2002 | 92 | 0.080 |
Why?
|
| Cell Division | 1 | 2011 | 744 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 166 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 142 | 0.080 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2010 | 69 | 0.080 |
Why?
|
| Neuromuscular Junction | 2 | 2002 | 92 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1418 | 0.080 |
Why?
|
| Actins | 1 | 2011 | 334 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 272 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 540 | 0.080 |
Why?
|
| Methacholine Chloride | 2 | 2011 | 16 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 468 | 0.080 |
Why?
|
| Texas | 1 | 2017 | 3632 | 0.070 |
Why?
|
| Myofibrils | 1 | 2008 | 25 | 0.070 |
Why?
|
| Connectin | 1 | 2008 | 29 | 0.070 |
Why?
|
| Fluoroscopy | 3 | 1999 | 100 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 70 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1008 | 0.070 |
Why?
|
| Calcium | 2 | 2004 | 1080 | 0.070 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2007 | 17 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 516 | 0.070 |
Why?
|
| Lung Volume Measurements | 3 | 1998 | 85 | 0.070 |
Why?
|
| Lipoproteins, LDL | 1 | 2007 | 133 | 0.070 |
Why?
|
| Plethysmography | 1 | 2006 | 36 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2008 | 422 | 0.060 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2006 | 59 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1554 | 0.060 |
Why?
|
| Spirometry | 2 | 2016 | 75 | 0.060 |
Why?
|
| Lung Compliance | 1 | 2005 | 19 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 238 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1423 | 0.060 |
Why?
|
| Positive-Pressure Respiration | 1 | 2005 | 85 | 0.060 |
Why?
|
| Respiration, Artificial | 3 | 2011 | 504 | 0.060 |
Why?
|
| Plethysmography, Whole Body | 1 | 2005 | 2 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2010 | 1049 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2005 | 45 | 0.060 |
Why?
|
| Finite Element Analysis | 1 | 2005 | 35 | 0.060 |
Why?
|
| Cell Shape | 1 | 2005 | 69 | 0.060 |
Why?
|
| Age Factors | 2 | 2017 | 2920 | 0.060 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2004 | 24 | 0.060 |
Why?
|
| Cyclin A | 1 | 2004 | 17 | 0.060 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2004 | 26 | 0.060 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 20 | 0.060 |
Why?
|
| Immunity, Active | 1 | 2004 | 6 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2004 | 51 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2004 | 113 | 0.050 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2003 | 8 | 0.050 |
Why?
|
| Free Radicals | 1 | 2003 | 33 | 0.050 |
Why?
|
| Embolism, Paradoxical | 1 | 2003 | 3 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 147 | 0.050 |
Why?
|
| Viscosity | 1 | 2003 | 36 | 0.050 |
Why?
|
| Sarcoglycans | 1 | 2003 | 8 | 0.050 |
Why?
|
| Muscle Spindles | 1 | 2003 | 5 | 0.050 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2003 | 12 | 0.050 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2003 | 17 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2003 | 21 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 37 | 0.050 |
Why?
|
| Motion | 1 | 2003 | 44 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2003 | 44 | 0.050 |
Why?
|
| Disease | 1 | 2004 | 127 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 89 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 58 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2002 | 54 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 109 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2003 | 120 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2004 | 435 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 159 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 181 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2003 | 82 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2001 | 796 | 0.050 |
Why?
|
| Acetylcholinesterase | 1 | 2002 | 23 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2003 | 127 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5410 | 0.050 |
Why?
|
| Comorbidity | 2 | 2017 | 1610 | 0.050 |
Why?
|
| Dissection | 1 | 2002 | 59 | 0.050 |
Why?
|
| Serine | 1 | 2022 | 166 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2004 | 413 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2002 | 181 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2002 | 380 | 0.040 |
Why?
|
| Inhalation | 1 | 2001 | 8 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2003 | 254 | 0.040 |
Why?
|
| Sarcomeres | 1 | 2001 | 33 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 2000 | 38 | 0.040 |
Why?
|
| Nonlinear Dynamics | 1 | 2000 | 52 | 0.040 |
Why?
|
| Bronchi | 1 | 2001 | 103 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2000 | 145 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2016 | 6569 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 666 | 0.040 |
Why?
|
| Abdomen | 1 | 2001 | 135 | 0.040 |
Why?
|
| Rats | 2 | 2010 | 3607 | 0.040 |
Why?
|
| Probability | 1 | 2000 | 322 | 0.040 |
Why?
|
| Prevalence | 2 | 2017 | 2663 | 0.040 |
Why?
|
| Arginine | 1 | 2022 | 343 | 0.040 |
Why?
|
| Binding Sites | 1 | 2003 | 1256 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2000 | 304 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2007 | 1006 | 0.040 |
Why?
|
| Ventilators, Mechanical | 1 | 1999 | 40 | 0.040 |
Why?
|
| LIM Domain Proteins | 2 | 2010 | 64 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 1980 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 552 | 0.040 |
Why?
|
| Connective Tissue Cells | 1 | 1998 | 5 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 6452 | 0.040 |
Why?
|
| Connective Tissue | 1 | 1998 | 28 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 1224 | 0.030 |
Why?
|
| Airway Obstruction | 1 | 1999 | 167 | 0.030 |
Why?
|
| Hydrostatic Pressure | 1 | 1997 | 10 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2017 | 5173 | 0.030 |
Why?
|
| Cell Count | 1 | 1998 | 234 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 46 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 3015 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2004 | 2511 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 436 | 0.030 |
Why?
|
| Symptom Flare Up | 1 | 2016 | 24 | 0.030 |
Why?
|
| Adult | 3 | 2009 | 31600 | 0.030 |
Why?
|
| Physical Endurance | 1 | 2016 | 45 | 0.030 |
Why?
|
| Caspases | 1 | 2017 | 166 | 0.030 |
Why?
|
| Mortality | 1 | 2018 | 263 | 0.030 |
Why?
|
| Software | 1 | 2000 | 731 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2016 | 253 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 1996 | 124 | 0.030 |
Why?
|
| Kinetics | 1 | 1997 | 1130 | 0.030 |
Why?
|
| Cough | 1 | 2016 | 96 | 0.030 |
Why?
|
| Dyspnea | 1 | 2016 | 160 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1255 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 714 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1499 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1444 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 2196 | 0.020 |
Why?
|
| Smooth Muscle Myosins | 1 | 2011 | 2 | 0.020 |
Why?
|
| Contractile Proteins | 1 | 2011 | 17 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2313 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1841 | 0.020 |
Why?
|
| United States | 2 | 2016 | 11675 | 0.020 |
Why?
|
| Actin Cytoskeleton | 1 | 2010 | 49 | 0.020 |
Why?
|
| Sclera | 1 | 1990 | 41 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 285 | 0.020 |
Why?
|
| Cataract Extraction | 1 | 1990 | 152 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3736 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 3402 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 5015 | 0.020 |
Why?
|
| Risk Factors | 2 | 2018 | 10944 | 0.020 |
Why?
|
| Integrin beta3 | 1 | 2007 | 29 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2007 | 56 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 71 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7123 | 0.020 |
Why?
|
| Cornea | 1 | 1990 | 569 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 652 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 679 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 868 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2009 | 937 | 0.010 |
Why?
|
| Aorta | 1 | 2007 | 552 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 623 | 0.010 |
Why?
|
| Extravehicular Activity | 1 | 2003 | 3 | 0.010 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2003 | 21 | 0.010 |
Why?
|
| Embolism, Air | 1 | 2003 | 24 | 0.010 |
Why?
|
| Astronauts | 1 | 2003 | 76 | 0.010 |
Why?
|
| Parasympathetic Nervous System | 1 | 2001 | 15 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2001 | 97 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2001 | 78 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1595 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 17391 | 0.010 |
Why?
|
| Video Recording | 1 | 1998 | 204 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1997 | 232 | 0.010 |
Why?
|
| Stroke | 1 | 2003 | 1083 | 0.010 |
Why?
|
| Algorithms | 1 | 2001 | 1723 | 0.010 |
Why?
|
| Adolescent | 1 | 2009 | 20557 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1990 | 334 | 0.000 |
Why?
|